IDEC-CE9 data

IDPH and SmithKline Beecham Pharmaceuticals announced that Phase II results show improved symptoms when the Primatized MAb was given to patients with RA. Data

Read the full 243 word article

How to gain access

Continue reading with a
two-week free trial.